Skip to main content
logo
Avery Dennison Corporation (AVY)
NYSE: AVY · Real-Time Price · USD
165.82
-1.95 (-1.16%)
Aug 1, 2025, 4:00 PM - Market closed

Verve Therapeutics Revenue

Avery Dennison had revenue of $2.22B in the quarter ending June 28, 2025, a decrease of -0.66%. This brings the company's revenue in the last twelve months to $8.74B, up 1.66% year-over-year. In the year 2024, Avery Dennison had annual revenue of $8.76B with 4.68% growth.

Revenue (ttm)
$8.74B
Revenue Growth
+1.66%
P/S Ratio
1.51
Revenue / Employee
$249,654
Employees
35,000
Market Cap
12.93B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 28, 20248.76B391.40M4.68%
Dec 30, 20238.36B-675.00M-7.47%
Dec 31, 20229.04B631.00M7.50%
Jan 1, 20228.41B1.44B20.61%
Jan 2, 20216.97B-98.60M-1.39%
Dec 28, 2019 Pro Pro Pro
Dec 29, 2018 Pro Pro Pro
Dec 30, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Jan 2, 2016 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Amazon.com670.04B
Toyota Motor320.78B
The Home Depot162.95B
Alibaba Group Holding137.30B
Tesla92.72B
Lowe's Companies83.24B
The TJX Companies56.99B
PDD Holdings55.49B
Revenue Rankings

AVY News

More News